Editor's Pic
Stem cell stocks: GERN, STEM, OSIR still riding high, but beware of politics
Published on March 11, 2009
Stem cell stocks like Stem Cells (STEM) and Geron (GERN) are capturing investor attention: But a look at the stock chart points at some Inconvenient Truths…
Potash: No Miracle Gro for your Portfolio
Published on March 5, 2009
Potash Corp./Saskatchewan (NYSE:POT) is being touted as ready for a breakout. We beg to disagree!
by J. Christoph Amberger
Baltimore—TFN: These days, you may argue that any equity investing is automatically contrarian investing. Worse, that buying stocks is an irrational gamble that reason will prevail and the political superstitions of the 19th and 20th centuries will be [...]
Spaghetti and organic foods… could this be the one remaining recession-proof sector?
Published on February 20, 2009
Where does the money go? Try American Italian Pasta Company (NASDAQ:AIPC)… or Amish Naturals, Inc. (OTC:AMNT)—maybe!
by J. Christoph Amberger
Baltimore—TFN: American Italian Pasta Company (NASDAQ:AIPC) has increased its shareprice 800% from a 52-week low around $4, to now trade at above $32. That’s about 60 times more than you’d pay for Fannie Mae, 15 more than you’s pay [...]
An up and coming biotech: Human Genome Sciences Inc. (HGSI)
Published on February 4, 2009
A lucrative government contract is just one of the things this small cap has going for it.
Stem Cell Mania: Cord Blood is the flavor of the day!
Published on January 27, 2009
Much like Geron (NASDAQ:GERN), Cord Blood America Inc. (OTC:CBAI) is benefiting from the belief in a new ear of medical miracles.
The year of Comcast (CMCSA)
Published on January 22, 2009
2009 government initiatives could mean big bucks for Comcast Corporation (NASDAQ:CMCSA).
Ally yourself with this video surveillance provider
Published on January 12, 2009
Digital Ally (NASDAQ:DGLY) is expecting a 50% increase in revenues in 2009. Pick up shares under $3.35.
Pick up shares of Service Corporation International (SCI)
Published on January 2, 2009
This death services company is ripe for investing. Consider it a “reality play”.
It’s time to buy Isis Pharmaceuticals (ISIS)
Published on December 17, 2008
The sale of its Ibis Biosciences, Inc. subsidiary to Abbott Labs makes this already promising biopharmaceutical company a good buy right now.
Argon ST (STST) may hold the key to future earnings in a war-weary world
Published on December 8, 2008
Defense contractors are casting a wary eye at the new administration. But Argon ST has the technology that will prove essential.
Rest easy with Vanda Pharmaceuticals Inc. (VNDA)
Published on December 2, 2008
This teeny biotech may have struck gold with it’s drug VEC-162. Created to treat insomnia and mood disorders, it’s ability to reset the body’s internal clock could help shift-workers and suffers of jet-lag.
The long dying of vice stocks: Short Las Vegas Sands (LVS) for 20-30% gains!
Published on November 14, 2008
Las Vegas Sands (NYSE: LVS) has been hard hit by recession. Despite talks of financing for their Macau project, there is really no hope for this stock. Short it now for 20-30% gains!
Profit referendum: How this election day could boost Penn National (PENN)
Published on October 31, 2008
Things are looking way up for Penn National Gaming Inc. (NASDAQ:PENN) and if Marylanders vote “yes” to slots this Nov. 4, they could get even better.
Potential double-digit gains by Oct 30 with SUNH
Published on October 27, 2008
This healthcare provider could see a quick jump in stock price on October 30 when its Q3 results are announced.
Crude prices plunge: Use an UltraShort ETF (DUG) to make 2-to-1 profits
Published on October 15, 2008
The global economy is screeching to a halt. Pretty soon, it will be obvious we are in reverse. That means oil prices will continue to plunge. Use an UltraShort ETF (AMEX:DUG) to profit from the downturn.
General Electric (GE): A blue chip bargain
Published on October 13, 2008
If the outlook is so bullish for Polycom (NASDAQ:PLCM) it warrants a $32 upside, how come the company’s insiders are selling their holdings between $21-27?
TFN Editor’s PIC: A micro cap with macro potential (STEM)
Published on October 6, 2008
If the outlook is so bullish for Polycom (NASDAQ:PLCM) it warrants a $32 upside, how come the company’s insiders are selling their holdings between $21-27?
TFN Editor’s PIC: A speculative buy with incredible potential (IDMC)
Published on September 25, 2008
If the outlook is so bullish for Polycom (NASDAQ:PLCM) it warrants a $32 upside, how come the company’s insiders are selling their holdings between $21-27?
Bring out the Vice Stocks: Altria Group Inc. (MO)
Published on September 16, 2008
If you want to be among the few investors making money in this market, buy shares of Altria Group (NYSE:MO) and go stand by the mailbox. That sexy dividend check should arrive soon.
Wall Street Implosion: Protect your assets with Vanguard Short-Term Bond Index ETF (BSV)
Published on September 16, 2008
With markets dropping everywhere, what should you do as an investor?
Follow TFN via RSS or Twitter |
 |
 |
 |
Advertisement
Editor's Pic
Digital Ally up 20% on record Q4 revenue – time to sell!
By
Laura Cadden
 |
Digital Ally (DGLY) has seen its share price jump 20% on record sales largely stemming from its DVM-750 in-car video system. TFN readers that took our advice last year and bought DGLY should cash in those gains!
Read more »
Recent Comments
- lil jon on Is Harley Davidson riding off into the sunset?
- Klaus Foehre on Is the silver run over? Coeur d’Alene Mines (CDE), Silver Wheaton (SLW), Alto Group (ALTO), Hecla Mining (HL), Endeavour Silver (EXK) close down
- Geothermal Costa Rica on Steepest drop since Feb. 2009: Here we go again!
- Costa Rica Farms on Steepest drop since Feb. 2009: Here we go again!
- arlenice on Geico drops Fox’s Glenn Beck: Amberger follows up